Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: Frequency and etiology

Neuropsychobiology

Volumn 33, Issue 3, 1996, Pages 142-146

  Windgassen, K W ^a   Wesselmann, U ^a   Mönking, Schulze ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b St Rochus Hospital Telgte   (Germany)

Author keywords

Galactorrhea; Neuroleptics; Schizophrenia

Indexed keywords

BENPERIDOL; BROMPERIDOL; BUTYROPHENONE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; PERAZINE; PERPHENAZINE; PHENOTHIAZINE DERIVATIVE; PROLACTIN; REMOXIPRIDE; SULPIRIDE; THIORIDAZINE; ZOTEPINE;

ADULT; ARTICLE; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; INCIDENCE; LATENT PERIOD; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; GALACTORRHEA; HUMANS; HYPERPROLACTINEMIA; PREGNANCY; SCHIZOPHRENIA;

EID: 0029889775     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119265     Document Type: Article

References (20)

1. Kalinowski LB, Hippius H, Klein HE: Biological Treatments in Psychiatry, New York, Grüne & Stratton, 1982.
2. Ackenheil M: Spektrum Psychopharmaka, Zug, Aesop, 1985.
3. Promonta Lundbeck Arzneimittel: Äquivalenztabelle für die neuroleptische Langzeittherapie, Hamburg, 1993.
4. Werder von K: Physiologie und Pathophysiologie der Regulation der Prolaktinsekrction; in Jürgenscn O (ed): Hyperprolaktinämie-Prolak-tinomc, Berlin, Springer, 1988, pp 3-14.
5. Zito JM, Sofair JB, Jaeger J: Self-reported neu-roendrine effects of antipsychotics in women: A pilot study, Ann Pharmacother 1990:24: 176-180.
6. Davis JM, Cole JO: Antipsychotic drugs; in Arieti S (ed): American Handbook of Psychiatry, ed 2, vol 5, New York, Basic Books, 1975, pp 441-475.
7. Neimcier R, Hauser GA, Keller M: Die pathologische Laktation, Schweiz Med Wochcnschr 1959;89:442-445.
8. Py O, Mathieu P: Galactorrhea et trouble du cycle menstruel au cours de traitements neuroleptiques, Presse Méd 1960:20:765-766.
9. Apostolakis M, Kapctanakis S: Plasma prolac-tin activity in patients with galactorrhea after treatment with psychotropic drugs: in Ciba Foundation (ed): Lactogenic Hormones, Wol-stenholme, Knight, 1972, pp 349-359.
10. Turkington RW: Prolactin secretion in patients treated with various drugs, Arch Intern Med 1972:130:349-354.
11. Inoue H, Hazarna H, Ogura C: Neuroendocrinological study of amenorrhea induced by antipsychotic drugs, Folia Psychiat Neurol 1980: 34:181.
12. Wesselmann U, Windgassen K: Galactorrhea: Subjective response by schizophrenic patients, Acta Psychiatr Scand 1995:91:152-155.
13. Bcumont PJ V, Gelder MG: The effects of phe-nothiazines on endocrine function, I, Patients with inappropriate lactation and amenorrhea, Br J Psychiatr 1974;124:413-419.
14. Meitzer HY: Effect of psychotropic drugs on neuroendocrine function, Psychiatr Clin North Am 1980;3:277-298.
15. Kleinberg DL, Gordon LN: Galactorrhea: A study of 235 cases, including 48 with pituitary tumors, N Engl J Med 1977:296:589-600.
16. Schurz B, Enzelsbcrger H, Kubista E: Die Wertigkeit der HPRL-Bestimmungim Rahmen der Galactorrhoc, Zcntralbl Gvnäkol 1989:111: 33-38.
17. Gutierrez G, Beltran AF, Solana IF, Hernandez JM: Correlation entre hiperprolactincmia y galactorrea, Ginecol Obstet Mex 1989:57:294-297.
18. Meitzer HY: Long-term effects of neuroleptic drugs on neuroendocrine system: in Kameli D, Racagni G (eds): Chronic Treatment in Neuro-psychiatry, New York, Raven Press, 1985, pp 59-68.
19. Peters F: Prolaktin und Erkrankungen der Brust, München, Urban & Schwarzenberg, 1986, pp 70-76.
20. Auerbach K, Avery JL: Induced lactation, A study of adoptive nursing by 240 women, Am J Dis Child 1981;135:340-343.